Does DURVALUMAB Cause Pulmonary embolism? 104 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Pulmonary embolism have been filed in association with DURVALUMAB (IMFINZI). This represents 0.6% of all adverse event reports for DURVALUMAB.
104
Reports of Pulmonary embolism with DURVALUMAB
0.6%
of all DURVALUMAB reports
27
Deaths
56
Hospitalizations
How Dangerous Is Pulmonary embolism From DURVALUMAB?
Of the 104 reports, 27 (26.0%) resulted in death, 56 (53.8%) required hospitalization, and 19 (18.3%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which DURVALUMAB Alternatives Have Lower Pulmonary embolism Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE